We cultured smooth muscle cells from rat renal preglomerular arterioles by injecting a suspension of iron oxide into the left ventricle, separating the arterioles magnetically, and growing cells from explants. In passaged cultures we ascertained vascular smooth muscle purity of >98% by morphology; contraction to norepinephrine and angiotensin; positive immunofluorescence staining through the sixth passage with monoclonal antibodies to smooth muscle-specific a-and y-isoactins, myosin, and desmin; and the absence of von Willebrand factor. Angiotensin II (10O-1-0-M) induced dose-dependent DNA synthesis and proliferation of subcultured (three times) arteriolar smooth muscle cells from a growth-arrested state (p<O.Ol). Angiotensin II (10-M) also induced the cells to express c-fos mRNA. We find no previous report of culture of smooth muscle cells from renal preglomerular arterioles. Our findings also provide evidence that angiotensin II is mitogenic to arteriolar muscle cells and thus may be involved in their hyperplasia accompanying hypertension
T nhe mechanism of the abnormal growth of vascular smooth muscle in hypertension is the subject of considerable investigation. Such growth may account for the elevated resistance of the established stages of hypertension' but may also be involved as an initiating factor.23 In addition to work hypertrophy, increasing evidence suggests that pressure-independent influences participate in this growth.2 4 Paracrineautocrine factors, including the renin-angiotensin system intrinsic to vascular walls, may play an important role. 8 In support of this hypothesis, angiotensin II (Ang II) has been found to increase growth of smooth muscle cells cultured from the aorta.
Several investigators9-11 have reported that the growth of cultured normal rat aortic smooth muscle stimulated by Ang II is primarily hypertrophic (characterized by increases in cell size) rather than hyperplastic (characterized by increases in cell number). This observation is compatible with the disease processes of chronic benign hypertension12; in rats with benign hypertension, aortic smooth muscle primarily undergoes hypertrophy.5 However, it is the growth of smooth muscle of resistance arteries rather than conduit arteries that is critical to the disease mechanisms of hyper-tension, and such growth has been reported to be primarily hyperplastic rather than hypertrophic. 4, 13 Thus, to support the hypothesis that vascular smooth muscle growth induced by Ang II accounts for the elevated arterial resistance of hypertension, there must be evidence for a mitogenic effect of Ang II on the smooth muscle of resistance arteries. We here first report the culture of smooth muscle cells from renal preglomerular arterioles and the mitogenic response of these cells to exposure to physiological levels of Ang II.
Materials and Methods

Isolation and Culture of Renal Arteriolar Smooth Muscle Cells
Sprague-Dawley maximum-barrier-maintained male rats (Zivic-Miller Laboratories, Inc., Zelienople, Pa.) weighing 150-200 g were fed standard rat chow (Purina Chow, Purina Mills, St. Louis, Mo.) and tap water ad libitum. Renal arteriolar smooth muscle cells (ASMCs) were cultured from explants of renal preglomerular arterioles isolated by a modification of the methods of Chaudhari et al14 for culture of renal arteriolar endothelial cells. Briefly, for each culture four rats were etheranesthetized, and a midline abdominal incision including the diaphragm was made, exposing the heart. Ten milliliters of a 5% (wt/vol) suspension of iron oxide particles (ferroso-ferric oxide, black, Aldrich Chemical Co., Mil GIBCO Laboratories, Grand Island, N.Y.]) was infused systemically through the left ventricle of the heart. The kidneys were removed and placed in ice-cold 1144 Circulation Research Vol 71, No 5 November 1992 culture medium I, pH 7.4, and the remaining procedures were carried out at 4°C. The kidneys were decapsulated and cut longitudinally into two halves; the cortical tissue was carefully dissected from the medulla and placed in 10 ml culture medium I. The cortical tissue was minced and dispersed by gently pressing it under a sterile wire cloth (stainless steel, 30 mesh, Small Parts, Inc. Miami, Fla.). The crude kidney cortical dispersion was transferred into sterile tubes, and the volume was increased to 30 ml with culture medium I. To separate the iron-laden microvessels, we held a magnet against the test tube while decanting the nonvascular tissue. The crude preparation of microvessels was resuspended in 15 ml culture medium I and gently triturated. The washing procedure was repeated four or five times until the supernatant was free of any tissue particles. The microvessels were pooled, placed in 25 ml culture medium I containing 0.6 mg/ml collagenase type I (Sigma Chemical Co., St. Louis, Mo.), and incubated at 37°C with constant shaking for [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] minutes. Microvessels were again magnetically separated from the nonvascular tissue. To separate glomeruli from the microvessels, we gently passed the suspension through a 20-gauge needle two or three times. The microvessel suspension was then transferred to an 80-,m sieve (Sigma) and washed with 30 ml cold culture medium I. Microvessels were finally suspended in 10 ml culture medium II (DMEM culture medium, penicillin [ Aliquots (5 ml) of the final suspension of microvessels were plated in 75-cm2 tissue culture flasks and incubated overnight at 37°C in 5% CO2-95% air at 98% humidity. The next day we added an additional 6 ml culture medium II to each flask. On the sixth day of incubation, we replaced the medium with fresh culture medium III (DMEM culture medium, penicillin [100 units/ml], streptomycin [100 ,ug/ml], NaHCO3 [13 mM ], HEPES [25 mM], and FCS [20%]). Thereafter, we changed this medium every second day until the monolayer of cells became confluent (approximately [14] [15] [16] 
days).
At this stage, the cells appeared to be a homogeneous population of ASMCs outgrowing from the arterioles. However, to reduce the possibility of undetected fibroblast contamination, we enriched the ASMCs at confluency by the method of Aviv et al,15 selectively removing fibroblasts, which attach to the culture surface more rapidly than vascular smooth muscle cells. Briefly, 4 ml of 0.01% trypsin in calciumand magnesium-free Hanks' balanced salt solution (HBSS, GIBCO) was added to each culture flask. The flasks were incubated at 37°C for 3-4 minutes, and approximately 75-80% of the trypsin solution was removed. The flasks were then incubated for an additional 10 minutes or until the cell layers separated. Ten milliliters of culture medium III was added to each flask, and the cells were separated by agitation and then magnetically separated from the microvessels. The cell suspension devoid of microvessels was plated and incubated for 20 minutes at 370C. blasts) were aspirated with the medium, transferred into other flasks, and incubated for an additional 20 minutes at 37°C; this enrichment process was repeated four times and followed by overnight incubation. The next day the medium was replaced by fresh culture medium III. The medium was changed every second day, and the ASMC enrichment procedures were repeated twice after the cells became confluent.
ASMC purity was ascertained by criteria similar to those we have previously reported16: characteristic morphology; contraction to norepinephrine and angiotensin II; positive immunofluorescence staining with smooth muscle-specific a-and y-isoactin, myosin, and desmin monoclonal antibodies; and the absence of von Willebrand factor.
As controls for these procedures, fibroblasts were also cultured from the rat renal preglomerular arterioles. Briefly, intact arterioles were isolated as described above but not digested with collagenase. The undigested microvascular suspension was separated from the glomeruli by sieving through a 100-,um nylon mesh and plated as explants in tissue culture flasks at 37°C, 95% humidity, and 95% air-5% CO, in the presence of culture medium III containing 10% FCS. Fibroblasts that grew from these explants were identified by characteristic morphology and further cultured after removing the arterioles. Comparative studies were also made with cultured human dermal fibroblasts kindly supplied by Dr. J.D. Baker, West Virginia University, cultured mouse 3T3-Swiss albino cells (contact inhibited fibroblasts, ATCC CCL 92, American Type Culture Collection, Rockville, Md.), and cultured rat aortic smooth muscle cells.16
Cell Characterization by Indirect Immunofluorescent Staining
We characterized the arteriolar smooth muscle cells using monoclonal antibodies to smooth muscle actin, myosin, and desmin: 1) CGA7 (Enzo Biochemical Inc., New York), an antibody that recognizes the y-and a-isoactins of growth-arrested, early-passaged smooth muscle and fails to react with skeletal, cardiac, or non-smooth muscle actin17; 2) antibody to smooth muscle a-actin'8 (anti-aSM-1, Sigma); 3) anti-smooth muscle myosin (ASMM, Amersham Corp., Arlington Heights, Ill.), which reacts with myosin heavy chain (200 kd) in vascular and visceral smooth muscle19; and 4) rabbit antibody to chicken smooth muscle desmin (AD, Accurate Chemical & Scientific Corp., Westbury, N.Y.), which reacts with intermediate filament protein. 20 Briefly, ASMCs in passages 3, 6, 12, and 24 were grown on multichamber cell culture slides (Nunc, Inc., Naperville, Ill.). After 2-5 days, the slides were washed twice in ice-cold phosphate-buffered saline (PBS) containing 3% bovine serum albumin (BSA, Sigma) and once in ice-cold PBS and were fixed by treating with -20°C methanol for 5 minutes (for staining with CGA7, anti-aSM-1, or AD) or with acetone (for staining with ASMM), as previously described. [17] [18] [19] [20] The slides were washed in PBS, blocked with 3% whole goat serum in PBS, and incubated for 60 minutes at room temperature in a humidified chamber with either CGA7 antibodies at a dilution of 1:500, anti-aSM-1 antibody at a dilution of 1: 400, AD antibodies at a dilution of 1:50, or ASMM antibodies at a Unattached cells (primarily ASMCs rather than fibrodilution of 1: 50 (all dilutions were made with PBS).
Subsequently, the slides were washed four times with PBS containing 3% BSA and incubated in the dark for 60-90 minutes with fluorescein isothiocyanate (FITC)labeled goat anti-mouse immunoglobulin G (IgG) [F(ab')2 fragment, Organon Teknika, Durham, N.C.] at a 1:20 dilution, FITC-labeled anti-mouse IgG (Sigma) at a dilution of 1:200, or goat anti-rabbit IgG-fluorescein (Miles Yeda Scientific Ltd.) at a dilution of 1:100. Unbound antibodies were removed by four washes in 3% BSA-PBS and by a final wash with PBS, and the cells were dehydrated with ethanol and fixed with fluoromount-G (Southern Biotechnology Associates, Inc., Birmingham, Ala.) for observation with a Zeiss Universal microscope equipped for epifluorescence. Negative controls included deletion of primary and secondary antibodies.
To detect endothelial cell contamination, ASMCs were passaged three times, cultured for 5 days, fixed in methanol, and stained for 60 minutes with monoclonal anti-von Willebrand factor antibodies (BioGenex Laboratories, San Ramon, Calif.) at a dilution of 1:50 and for 30 minutes with FITC-labeled goat anti-rabbit IgG at a dilution of 1:100. Otherwise, the procedure was similar to that described above. Bovine brain microvascular endothelial cells cultured by the method of Audus and Borchardt2' were used as a positive control.
Purity of cultured ASMCs was assessed quantitatively by randomly counting at least 1,600 cells for each stain. The percentage of cells showing strong or medium fluorescence or with prominent stress fibers when stained with CGA7, ASMM, AD, aSM-1, or anti-von Willebrand factor antibodies was calculated.
Cell Characterization by Contraction
We evaluated the contraction of cultured ASMCs in response to Ang 11 (10-9 and 10-5 M, Sigma) or norepinephrine (NE, 10`M, Sigma) using a phase-contrast microscope (model CK2, Olympus Corp., Lake Success, N.Y.) fitted with a photographic attachment. Briefly, ASMCs maintained at 37°C in 95% 02-5% CO2 were grown on multichamber glass slides, washed with Krebs-Ringers bicarbonate (KRB) buffer, pH 7.4, containing 2 mM CaCl2, and then treated with KRB buffer containing NE or Ang II. Photomicrographs (x200-x480) were taken at 0 minutes (before treatment) and 1 minute after initiation of treatment. A rapid contraction (within 1 minute) after treatment with NE or Ang II followed by relaxation after washout of agonist was considered a positive response.
Detection of c-fos mRNA Expression by Northern Blot Analysis
ASMCs (passaged three times) cultured to confluence (2x 107 cells per 75-cm2 flask) in culture medium II were growth-arrested22 by placing them for 48 hours in culture medium III devoid of serum but containing 5 x 10 M insulin (Sigma), transferrin (5 ,ug/ml), and ascorbate (0.2 mM). Growth-arrested ASMCs were treated for 15, 30, 45, or 60 minutes with 10-5 M Ang II (Sigma) in 5 ml DMEM containing NaHCO3 (13 mM) and HEPES (25 mM). RNA was ether-extracted from the smooth muscle cells by the method of Chomczynski and Sacchi. 23 Briefly, 20 ,g total RNA, quantified by ultraviolet spectrophotometry, was separated by 1% agarose/1 M formaldehyde gel electrophoresis.24 Gels were treated with a mixture of 0.05N NaOH-0.15 M NaCl for 30 minutes and then with 0.1 M Tris-0.15 M NaCl, pH 7.5, and subsequently blotted for 3 hours onto a nylon membrane ( Briefly, we synthesized a radioactive (32P-labeled) DNA probe from a synthetic 40-base oligonucleotide c-fos DNA probe (Oncogene), using T4 polynucleotide kinase (BRL, Gaithersburg, Md.), and [y-32P]ATP. We purified the resulting probe by filtering through a Sephadex G25 column (Pharmacia). Blots were prehybridized for 1 hour at 65°C in a solution of 1 M NaCl, 50 mM Tris-HCl, 10% dextran sulfate, 1% sodium dodecyl sulfate (SDS), and 100 ,ug denatured nonhomologous salmon sperm DNA (Sigma). Blots were subsequently hybridized overnight at 65°C in the presence of 2.5 x 106 cpm probe. Then the membranes were washed with SSC with or without 0.1% SDS, air-dried, exposed to x-ray film (Kodak X-Omat AR, Sigma) for 3-6 days at -80°C, and then developed.
Growth Curves
Confluent ASMCs in the third passage were washed with calcium-magnesium-free PBS, harvested by adding 4 ml trypsin solution (0.25% trypsin in calcium-magnesium-free HBSS, pH 7.4), and washed twice with 10 ml culture medium III containing 10% FCS. The final cell pellet was suspended in culture medium III containing 0.4% FCS. Aliquots (0.5 ml) of homogeneously suspended ASMCs containing 2.5 x 104 cells were plated in each well of eight-well tissue culture multiplates (LUX, Miles Scientific Inc., Naperville, Ill.) and incubated overnight at 37°C in 5% C02-95% air at 98% humidity.
Culture medium III (0.5 ml) containing 0.4% FCS was added to each well the next day. On the third day after plating and thereafter, this medium was replaced every 8 hours by 1 ml of the same medium with added 0, 10-12, 10-9, or 10`M Ang II (Sigma) or added 9.6% FCS.
Cells were counted on days 0, 3, 4, 5, 7, 10, and 14. For cell counts, cultures were washed with calcium-magnesium-free PBS, harvested with 0.5 ml trypsin-EDTA (0.05% trypsin and 0.02% EDTA), diluted in isoton-II ( For [3H]thymidine incorporation, ASMCs in the third passage were plated in a 24-well tissue culture dish, fed culture medium III containing 10% FCS for 48 hours, and maintained at 37°C in 95% air-5% CO2 at 95% humidity. Then the cells were growth-arrested by feeding them culture medium III containing 0.4% FCS for 48 hours. Growth-arrested ASMCs were treated for 10 hours with Ang 11 (10-12, 1(01), 10 -7, or 10 M, Sigma) in the presence of fresh culture medium III containing 0.4% FCS. Ang 11 treatment was then repeated in the presence of [jHjthymidine; cells were pulsed with 1 gCi/ml at 37°C. After 14 hours, the cells were washed twice with ice-cold PBS and then twice with 10% trichloroacetic acid. The precipitate was solubilized by addition of 500 gl of 0.3N NaOH and 0.1% SDS and incubation at 37°C for 4 hours. Aliquots (0.5 ml) from four wells for each treatment, with 15 ml scintillation fluid, were counted in a liquid scintillation counter. Each experiment was repeated three times.
For immunofluoreseent staining of proliferating nuclei, ASMCs were plated in multichamber slides and allowed to grow before inducing growth arrest, as described above. After an initial treatment of growtharrested ASMCs for 10 hours with Ang II (Sigma), the cells were treated with fresh Ang II for 14 hours in the presence of 10 ,M BrdU. The cells were then washed twice with ice-cold PBS containing 3% BSA, followed by two washes with PBS. The cells were fixed with ice-cold absolute methanol and air-dried. After the cells were washed with PBS, they were treated for 60 minutes with 2N HCI to denature the DNA. The acid was then neutralized by washing the slides four times for 5 minutes each with 0.1 M borate buffer, pH 8.5 . We then incubated the PBS-washed cells for 60 minutes in the dark in a humidified chamber with FITC-conjugated anti-BrdU monoclonal antibodies (50 gg/ml, antibody diluted in PBS containing 0.1% BSA). The slides were washed twice with PBS containing 1% BSA and three times with PBS for 10 minutes each, dehydrated with ethanol, and mounted with fluoromount-G for observa-tion under a fluorescence microscope. ASMCs treated with 0.4% FCS, 10% FCS, and deletion of primary and secondary antibodies were used as negative and positive controls. The percentage of immunofluorescent nuclei was assessed quantitatively by randomly counting at least 1,500 cells in each experiment. Each experiment was repeated three times. 
Results
With the iron oxide perfusion technique, we obtained renal preglomerular arterioles ranging in size from 80 to 200 ,uM. There was sparse glomerular and tubular tissue around the microvessels of the crude arteriolar preparation ( Figure 1 ), but after collagenase digestion, >98% of microvessels were free of contaminating tissue. When plated, >90% of the arterioles attached to the surface of the culture flasks, and cells could be seen proliferating from the outer surface of the explants 3-4 days after plating. The proliferating cells appeared to be smooth muscle, and we did not see cobblestone-shaped cells. Thus, the cells were fusiform, flattened, and irregularly shaped with a central nucleus and perinuclear granules (Figure 2) , consistent with the morphology of vascular smooth muscle cells in tissue culture.26-28 An apparently homogeneous population of ASMCs was obtained after the fourth enrichment procedure. In subcultures in the presence of 10% FCS, plating efficiency was approximately 85-90%, and the cells grew exponentially, doubling every 1.5-2 days, achieving confluence by [14] [15] [16] days. The cells grew vigorously in the characteristic hill-and-valley pattern27 and were successfully passaged 24 times.
More than 86% of ASMCs passaged three times, two days after passage, contracted in response to NE (10, agonists have contractile effects on renal preglomerular arterioles. 29 The contraction to both NE and Ang 1 was rapidly reversed on washing with KRB buffer. The contractile response of cultured ASMCs changed with time. The percentage of contracting cells was reduced to <8% after 7 days in culture. However, posteonfluent monolayers of ASMCs after 20 days in culture again showed the contractile response to Ang II.
Immunochemistry
We used CGA7 and anti-aSM-1 monoclonal antibodies to detect the presence of smooth muscle-specific a-A C and y-actin isoforms in monolayers of cultured ASMCs. These antibodies do not react with nonmuscle actin found in fibroblasts and other cell types. We also used ASMM and AD monoclonal antibodies to detect the presence of smooth muscle-specific myosin heavy chain and the intermediate filament protein desmin, respectively. More than 1,600 cells were counted for each marker. In ASMCs after the third passage, 2 days after plating, the CGA7 antibodies (Figure 4 , top panel) and ASMM antibodies ( Figure 5A ) decorated actin and myosin linear fibers, respectively. Cell counting showed that 98±2% and 95±3% of the ASMCs were positively stained with CGA7 and ASMM, respectively. Intense positive immunofluorescence in 99± 1% of ASMCs was also observed when reacted with the AD antibody ( Figure SB) . Almost all (98±2%) of the ASMCs additionally expressed immunofluorescence when stained with anti-aSM-1 antibody 5 days after plating (Figure 4 , bottom panel). Renal and dermal fibroblasts showed no cytoplasmic staining with any of these antibodies, whereas aortic smooth muscle cells expressed immunofluorescence with all antibodies. No immunofluorescence was detected when primary or secondary antibodies were deleted. Cultured ASMCs were not positively stained when reacted with antibodies to von Willebrand factor; however, brain microvascular endothelial cells showed intense immunofluorescence.
To detect change in the phenotype of cultured ASMCs with passage, we reacted cells in the sixth, 12th, and 24th passages with monoclonal antibodies to actin, myosin, and desmin. Again, 1,600 or more cells were counted for each marker. More than 90% of the cells at all passages were positively stained with anti-aSM-1 and myosin antibodies. More than 90% of the ASMCs in the sixth passage showed staining with AD antibodies similar to that seen in the cells in the third passage ( Figure SB) . However, positive reactivity to AD antibodies was markedly reduced in ASMCs at the 12th passage ( Figure SC) , where the number of positively stained cells was only 3+1%; staining was absent at the 24th passage (data not shown). These Arteriolar smooth muscle cells 2 days afterplating labeled with anti-smooth muscle desmin antibody. Panel C: Arteriolar smooth muscle cells (passaged 12 times) 2 days after plating labeled with anti-smooth muscle desmin antibody.
Effect of Ang 11 on Expression of c-fos r
Treatment of growth-arrested ASMOr Ang 11 caused a rapid increase in c-fos ( Figure 6 is representative of three N( Basal expression of c-fos mRNA in the gi ASMCs was low, similar to observatioi aortic smooth muscle.22"'3 c-fos mRNA creased at 30 minutes of treatment with ! significantly expressed for as long as 1 I the expression pattern of c-fos mRNA treated with Ang 11.22,30) Effect ofAng II on Growth ofASMCs ASMC number increased in a conceni dent manner (p<0.01) after treatment wincrease in cell number (Figure 7 ) was evi as early as 24 hours after treatment, wil 0.4% FCS remaining growth-arrested f growth curve. Physiological concentratioi Ang II increased cell number by up t control cells in 0.4% FCS (mean±SEM ments): +19±5% on day 2 of treatm( +86±15% on day 3 (p<0.01), +127±K (p<0.01), +161+18% on day 8 ( +164±15% on day 12 (p<0.01). At plal ANG 10-5 M C 0 15 30 45 60 min FIGURE 6 . Time course of induction of c angiotensin II (ANG). Growth-arrested art muscle cells were exposed to J05MANG or [C]) for the times indicated. The figure repres blot analysis of total RNA hybridized to`P This experiment was reproduced three times. ,nRNA the cells appeared healthy, growth in 10`M Ang II was s with 10`M significantly lower than that in 10% FCS (p<0.01).
mRNA levels
To further investigate the possibility that cellular )rthern blots). toxicity induced by Ang II accounts for the lower rowth-arrested plateau, we assessed the numbers of dead cells present ns in cultured in the supernatant medium on days 0, 3, 4, 5, 7, 10, and expression in-14 after plating in the presence and absence of Ang II; kng II and was < 1 % of dead cells was found. We also used Trypan blue our, similar to staining to assess cell viability, detecting no change of aortic cells attributable to Ang II (<2% for all values). Additionally, there was no significant release of lactate dehydrogenase into the supernatant of 10`M Ang II-treated ASMCs during the entire culture period. tration-depen-Exposure of growth-arrested ASMCs to Ang 11 for 24 ith Ang II. An hours also resulted in a significant, concentration-dedent (p<0.01) pendent stimulation of [3H]thymidine incorporation th the cells in (Figure 8 ). In the presence of 0.4% FCS, physiological for the entire concentrations of 10" and 10`M Ang II increased ns (10`M) of [3H]thymidine incorporation by 405±50% (p<0.01) to 164% over and 549+86% (p<0.01), respectively. An increase of , n =3 experi-690+68% (p<0.01) was observed at 10`M, signifient (p<0.01), cantly less than that induced by 10% FCS (1,496±184%, ?3% on day 5 p<0.01). Longitudinal studies of [3H]thymidine incor-)<O.01), and poration into ASMCs treated with 10`M Ang II teau, although showed a significant increase in ['HIthymidine incorporation over days [1] [2] [3] [4] [5] [6] [7] (three experiments [cpm; mean+SEM]: 4,521 ±465 on day 1, 7,757±549 on day 4, and 9,413+540 on day 7). However, on day 10, the [3H]thymidine incorporation fell to levels observed on <28 S day 1 (3,763+21) . This observation also provides evi-K 28 S dence against the possibility of excess cell death at plateau from Ang 11 toxicity.
In growth-arrested ASMCs treated with Ang II, there was additional immunofluorescence evidence for nu- (1 , uCi/ml) . Aliquots from four wells were counted for each treatment and values are expressed as mean +SEM. ANG-II (10-o-10-5 M) resulted in significantly greater labeling (p<0.01) than the 0.4% FCS control group. Similar results were obtained in three independent experiments. veloped by Chaudhari et al14 for culturing endothelial cells from preglomerular arterioles of rabbits. We validated the identity of our passaged cells by their characteristic morphology; their contractile responses to norepinephrine and angiotensin II; the presence in the cells of characteristic a-and y-actins, myosin, and desmin; and the lack of von Willebrand factor. At least 86% of the cells passaged three or four times contracted, and at least 98% had positive immunofluorescence reactions to a-and y-actin, myosin, and desmin antibodies and negative reaction to von Willebrand factor antibodies, providing good evidence against significant fibroblast or endothelial contamination. Growth of ASMCs in culture with 10% FCS was robust, doubling every 36-48 hours to achieve confluence by 14-16 days, and we subcultured the ASMCs up to the 24th passage. In these cells, phenotypic actin and myosin expression remained stable through the 24th passage, but desmin expression decreased after the sixth passage. It should be noted that this isolation method would allow selection for culture of preglomerular arterioles within a defined size range, although such a selection was not done in the present study.
We find no previous report of culture of smooth muscle cells from renal arterioles. Regarding the culture of nonrenal arteriolar smooth muscle, Gunther et al,31 in 1982, reported culturing cells from rat mesenteric arteries, most of which had the electron microscopic morphology of smooth muscle and a proportion of which contracted in response to Ang II or epinephrine. However, the size of vessels harvested for culture was not specified, and the cultures likely represented a mixture of cells from conduit arteries, resistance arteries, and true arterioles (<200 gm); others, using similar harvesting techniques for morphometric studies, reported that the mesenteric arteries ranged in lumen size from 700 to 40 gfm.32 Similar methods were also used by Lyall and colleagues3334 to culture mesenteric artery cells. Again the specific source and the identity of the cells were not established. These investigators examined the growth effects of Ang II, reporting evidence of proliferation. However, the growth studies were performed in the presence of 2.5-10% FCS, and the effect of Ang II on the proliferation of growth-arrested cells was not documented. More recently Seidel et al, 35 using digestion and sieving techniques on cortical fragments, reported culturing cerebral arteriolar smooth muscle cells. However, the investigators provided no evidence that their preparation was purely arteriolar, not containing venular smooth muscle, and they did not study growth responses to Ang II.
Thus, we believe the present study represents the first report of culture of arteriolar smooth muscle cells (certainly of renal arteriolar cells) and the first observation of a mitogenic effect of Ang II on the growth of arteriolar smooth muscle cells.
We used growth-arrested, third-passaged ASMCs to assay responses to Ang II, including physiological ranges (10`M). In addition to measurements of DNA synthesis, we studied effects on cell numbers to detect proliferation. We also studied effects on expression of c-fos mRNA. Exposure of cells growth-arrested in serum-free medium to 10`M Ang II significantly increased c-fos mRNA expression in 30 minutes, as in aortic cells.2236 Studies in cells growth-arrested by low concentrations of serum indicated a clear, dose-related mitogenic effect of Ang II (p<0.01). (It should be noted that methods of cell growth arrest differed in our two studies, so cross comparisons between protooncogene expression and proliferation must be made with caution). Although at plateau, the density of cells exposed to Ang II was significantly lower than that of cells grown in 10% FCS, we detected no evidence of toxicity or accelerated cell death in the former. These results suggest that the ASMCs treated with Ang II were density growth limited, but we did not investigate that possibility or its mechanisms further.
A proliferative response of cultured normal rat aortic smooth muscle cells to Ang II was not observed in previous studies by Geisterfer et al, 9 Berk et al,'1' or Paquet et al,1' although the cells were derived by enzyme digestion rather than by explant, and the latter group reported proliferation of growth-arrested aortic smooth muscle cultured from spontaneously hypertensive rats. The response to Ang II of rat aortic cells cultured from explants, as our ASMCs were, has not been reported. However, Campbell-Boswell and Rob-ertson37 did report evidence for increases in the number of human smooth muscle cells cultured from aortic explants in response to Ang II treatment but not in serum-deprived cells. Furthermore, they did not measure DNA synthesis or distinguish changes in proliferation from changes in cell turnover.
The increased resistance in hypertension involves smaller arteries and arterioles rather than the aorta. However, far less is known about the growth characteristics in hypertension of vascular smooth muscle from these small vessels. There is evidence for hyperplasia, rather than hypertrophy, of resistance artery smooth muscle,4 suggesting that growth mechanisms in hypertension may differ in resistance and conduit arteries. It has been suggested that the hypertrophy of smooth muscle of conduit arteries may be more pressure related, whereas the hyperplasia of smooth muscle of resistance arteries may more represent pressure-independent growth processes,4-5 perhaps involving paracrine-autocrine systems.
Little is known about paracrine-autocrine systems in the walls of resistance-sized arteries. There is one report suggesting that an intrinsic renin-angiotensin system may be present in the walls of renal arterioles.38 Renal afferent arterioles display Ang 1I receptors39 and respond with vasoconstriction to Ang II'.4 Ang II released into the extravascular space,4' presumably by the juxtaglomerular apparatus, may also function as a para-crine system for the cells of the walls of the renal preglomerular arterioles.
In conclusion, the results of the present study provide evidence for the successful culture of arteriolar smooth muscle cells and their mitogenic response to physiological levels of Ang II. Thus, the results of the present study incriminate Ang II in the hyperplastic response of the smooth muscle of resistance arteries and arterioles in hypertension. Such growth processes in the renal arterioles6,42-44 may be importantly involved in the maintenance, and perhaps the initiation, of the hypertensive process. 45 
